levothyroxine sodium zentiva
zentiva k.s. - levotiroksino natrio druska - geriamasis tirpalas - 25 µg/5 ml - levothyroxine sodium
levothyroxine sodium zentiva
zentiva k.s. - levotiroksino natrio druska - geriamasis tirpalas - 50 µg/5 ml - levothyroxine sodium
levothyroxine sodium zentiva
zentiva k.s. - levotiroksino natrio druska - geriamasis tirpalas - 100 µg/5 ml - levothyroxine sodium
risperidone teva
teva pharma b.v. - risperidonas - milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai - 25 mg - risperidone
risperidone teva
teva pharma b.v. - risperidonas - milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai - 37,5 mg - risperidone
risperidone teva
teva pharma b.v. - risperidonas - milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai - 50 mg - risperidone
atixarso
krka, d.d., novo mesto - tikagreloras - plėvele dengtos tabletės - 60 mg - ticagrelor
atixarso
krka, d.d., novo mesto - tikagreloras - plėvele dengtos tabletės - 90 mg - ticagrelor
celsunax
pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostikos radiofarmaciniai preparatai - Šis vaistas yra skirtas tik diagnostikai. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. suaugusių pacientų, padėti atskirti tikėtina demencija su lewy įstaigos nuo alzheimerio ligos. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
ticagrelor mylan
viatris limited - tikagreloras - plėvele dengtos tabletės - 90 mg - ticagrelor